Azaryan E, Sarfi S, Hosseini SF, Saharkhiz M, Vazifeshenas-Darmiyan K, Naseri M. Effect of Elaeagnus Angustifolia extract on in vitro wound healing of human dermal fibroblast cells.
BMC Res Notes 2023;
16:364. [PMID:
38066640 PMCID:
PMC10709851 DOI:
10.1186/s13104-023-06644-0]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Accepted: 11/29/2023] [Indexed: 12/18/2023] Open
Abstract
AIM
The purpose of this study was to determine the impact of Elaeagnus Angustifolia extract (EA) on human dermal fibroblast (HDF) survival, migration, and wound healing-related genes.
METHODS
After preparing the hydroalcoholic extract of EA, MTT and scratch tests were used to determine the effect of EA on the viability and migration of HDFs. In addition, the quantitative polymerase chain reaction (q-PCR) was conducted to evaluate the impact of EA on the expression of wound healing-related genes in HDFs.
RESULT
According to the MTT test, a nontoxic concentration of EA (100 µg/ml) was obtained for further investigations. The scratch test results demonstrated that EA improved HDFs' capacity to migrate when compared to the control group. Additionally, q-PCR results revealed that EA could significantly increase wound healing-related genes (VEGF-A, HLA-G5, and IL-6) in comparison with the control group.
CONCLUSIONS
The EA could have a significant impact on the viability and migration of HDFs. Also, EA increased the expression of wound healing-related genes.
Collapse